 Joanna Etra
Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascularized Composite Allotransplantation | 10 | 2021 | 31 | 2.900 |
Why?
| | Graft Rejection | 8 | 2021 | 620 | 1.920 |
Why?
| | Skin Transplantation | 3 | 2021 | 85 | 0.790 |
Why?
| | Hindlimb | 2 | 2019 | 128 | 0.740 |
Why?
| | Wounds, Stab | 1 | 2021 | 12 | 0.710 |
Why?
| | Isoantibodies | 2 | 2018 | 60 | 0.690 |
Why?
| | Myocutaneous Flap | 1 | 2020 | 10 | 0.680 |
Why?
| | Superficial Back Muscles | 1 | 2020 | 14 | 0.680 |
Why?
| | Amputation, Traumatic | 1 | 2020 | 20 | 0.660 |
Why?
| | Blast Injuries | 1 | 2020 | 48 | 0.640 |
Why?
| | Arm | 1 | 2020 | 104 | 0.630 |
Why?
| | Mammaplasty | 2 | 2020 | 105 | 0.620 |
Why?
| | Vascular Grafting | 1 | 2019 | 13 | 0.610 |
Why?
| | Immune Tolerance | 2 | 2019 | 362 | 0.610 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2019 | 18 | 0.610 |
Why?
| | Femoral Vein | 1 | 2019 | 34 | 0.600 |
Why?
| | Violence | 1 | 2021 | 257 | 0.570 |
Why?
| | Skin | 2 | 2020 | 751 | 0.560 |
Why?
| | Bilirubin | 2 | 2016 | 97 | 0.560 |
Why?
| | Wounds, Gunshot | 1 | 2021 | 220 | 0.550 |
Why?
| | Hepatectomy | 2 | 2016 | 249 | 0.500 |
Why?
| | Anterior Compartment Syndrome | 1 | 2016 | 3 | 0.500 |
Why?
| | Pancreas Transplantation | 3 | 2020 | 75 | 0.480 |
Why?
| | Renal Dialysis | 1 | 2019 | 435 | 0.460 |
Why?
| | Diagnostic Errors | 1 | 2016 | 170 | 0.450 |
Why?
| | Hepatic Insufficiency | 1 | 2014 | 4 | 0.450 |
Why?
| | Coronary Artery Bypass | 1 | 2016 | 233 | 0.430 |
Why?
| | Graft Survival | 6 | 2020 | 534 | 0.390 |
Why?
| | Swine | 4 | 2023 | 773 | 0.350 |
Why?
| | Kidney Transplantation | 3 | 2020 | 701 | 0.310 |
Why?
| | Myocardial Infarction | 1 | 2016 | 1041 | 0.290 |
Why?
| | Organ Preservation | 2 | 2019 | 102 | 0.290 |
Why?
| | Microsurgery | 2 | 2019 | 75 | 0.260 |
Why?
| | Organ Transplantation | 2 | 2019 | 248 | 0.250 |
Why?
| | Time Factors | 5 | 2019 | 6808 | 0.210 |
Why?
| | Central Venous Catheters | 1 | 2023 | 51 | 0.200 |
Why?
| | Tissue Donors | 3 | 2020 | 417 | 0.190 |
Why?
| | Databases, Factual | 2 | 2021 | 1351 | 0.190 |
Why?
| | Retrospective Studies | 9 | 2021 | 15504 | 0.190 |
Why?
| | Upper Extremity | 2 | 2021 | 99 | 0.180 |
Why?
| | Catheterization, Central Venous | 1 | 2023 | 111 | 0.180 |
Why?
| | Baltimore | 1 | 2021 | 58 | 0.180 |
Why?
| | Animals | 12 | 2023 | 36847 | 0.170 |
Why?
| | Perfusion | 2 | 2019 | 211 | 0.170 |
Why?
| | Immunosuppressive Agents | 3 | 2020 | 889 | 0.170 |
Why?
| | Transplantation, Autologous | 2 | 2019 | 238 | 0.170 |
Why?
| | Abdominal Wall | 1 | 2019 | 24 | 0.160 |
Why?
| | Postoperative Complications | 4 | 2019 | 2639 | 0.160 |
Why?
| | Scrotum | 1 | 2019 | 27 | 0.160 |
Why?
| | Chimerism | 1 | 2019 | 31 | 0.160 |
Why?
| | Transplantation Chimera | 1 | 2019 | 54 | 0.160 |
Why?
| | Transplantation Tolerance | 1 | 2019 | 36 | 0.160 |
Why?
| | Swine, Miniature | 1 | 2019 | 82 | 0.150 |
Why?
| | Transplantation | 1 | 2019 | 34 | 0.150 |
Why?
| | Tissue and Organ Procurement | 2 | 2020 | 314 | 0.150 |
Why?
| | Cryobiology | 1 | 2018 | 1 | 0.150 |
Why?
| | Perioperative Period | 1 | 2019 | 56 | 0.150 |
Why?
| | Regenerative Medicine | 1 | 2019 | 47 | 0.150 |
Why?
| | Vascular Patency | 1 | 2019 | 103 | 0.150 |
Why?
| | Postoperative Care | 1 | 2020 | 261 | 0.150 |
Why?
| | Follow-Up Studies | 5 | 2019 | 5106 | 0.150 |
Why?
| | Male | 14 | 2021 | 67311 | 0.150 |
Why?
| | Drug Prescriptions | 1 | 2020 | 243 | 0.150 |
Why?
| | Composite Tissue Allografts | 1 | 2018 | 8 | 0.150 |
Why?
| | Humans | 21 | 2021 | 136765 | 0.140 |
Why?
| | Georgia | 2 | 2016 | 84 | 0.140 |
Why?
| | Pain, Postoperative | 1 | 2020 | 265 | 0.140 |
Why?
| | Amputees | 1 | 2019 | 95 | 0.140 |
Why?
| | Intraoperative Complications | 1 | 2019 | 138 | 0.140 |
Why?
| | Desensitization, Immunologic | 1 | 2018 | 95 | 0.130 |
Why?
| | Hyperbilirubinemia | 1 | 2016 | 13 | 0.130 |
Why?
| | Arteries | 1 | 2019 | 269 | 0.130 |
Why?
| | Treatment Outcome | 5 | 2019 | 10745 | 0.130 |
Why?
| | Reoperation | 1 | 2019 | 573 | 0.130 |
Why?
| | Heart Arrest | 1 | 2020 | 338 | 0.120 |
Why?
| | Implant Capsular Contracture | 1 | 2015 | 5 | 0.120 |
Why?
| | Biopsy | 1 | 2019 | 1124 | 0.120 |
Why?
| | Artificial Limbs | 1 | 2019 | 199 | 0.120 |
Why?
| | Female | 12 | 2021 | 72795 | 0.120 |
Why?
| | Feasibility Studies | 1 | 2019 | 951 | 0.110 |
Why?
| | Tissue Engineering | 1 | 2019 | 418 | 0.110 |
Why?
| | Lower Extremity | 1 | 2019 | 423 | 0.110 |
Why?
| | Multivariate Analysis | 2 | 2016 | 1507 | 0.110 |
Why?
| | Video-Assisted Surgery | 1 | 2013 | 4 | 0.110 |
Why?
| | Liver Regeneration | 1 | 2014 | 46 | 0.110 |
Why?
| | Mammography | 1 | 2015 | 152 | 0.110 |
Why?
| | Young Adult | 4 | 2021 | 13127 | 0.110 |
Why?
| | Incidence | 1 | 2021 | 2792 | 0.110 |
Why?
| | Lip | 1 | 2013 | 23 | 0.110 |
Why?
| | Facial Injuries | 1 | 2013 | 21 | 0.110 |
Why?
| | Bites and Stings | 1 | 2013 | 32 | 0.110 |
Why?
| | Hospital Costs | 1 | 2014 | 116 | 0.100 |
Why?
| | Middle Aged | 6 | 2019 | 33228 | 0.100 |
Why?
| | Mouth Mucosa | 1 | 2013 | 92 | 0.100 |
Why?
| | Orthopedic Procedures | 1 | 2016 | 216 | 0.100 |
Why?
| | Chi-Square Distribution | 1 | 2014 | 530 | 0.100 |
Why?
| | Early Diagnosis | 1 | 2014 | 240 | 0.100 |
Why?
| | Lymph Node Excision | 1 | 2013 | 170 | 0.100 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1571 | 0.100 |
Why?
| | Surgical Flaps | 1 | 2013 | 130 | 0.100 |
Why?
| | Adult | 8 | 2021 | 37631 | 0.100 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3265 | 0.100 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2018 | 614 | 0.100 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 992 | 0.100 |
Why?
| | Disease Models, Animal | 2 | 2020 | 4282 | 0.090 |
Why?
| | Pancreatectomy | 1 | 2014 | 252 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1301 | 0.090 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2822 | 0.090 |
Why?
| | Up-Regulation | 1 | 2014 | 844 | 0.090 |
Why?
| | Aged | 5 | 2019 | 23794 | 0.090 |
Why?
| | Adipose Tissue | 1 | 2015 | 630 | 0.090 |
Why?
| | Penis | 2 | 2020 | 36 | 0.080 |
Why?
| | Laparoscopy | 1 | 2014 | 464 | 0.080 |
Why?
| | Transplantation, Isogeneic | 2 | 2019 | 17 | 0.080 |
Why?
| | Rats, Inbred Lew | 2 | 2019 | 114 | 0.080 |
Why?
| | Risk Assessment | 2 | 2019 | 3432 | 0.080 |
Why?
| | Predictive Value of Tests | 1 | 2014 | 2022 | 0.070 |
Why?
| | Transplantation, Homologous | 2 | 2020 | 415 | 0.070 |
Why?
| | Veterans | 1 | 2020 | 1466 | 0.070 |
Why?
| | Aged, 80 and over | 3 | 2016 | 7585 | 0.070 |
Why?
| | Tacrolimus | 2 | 2020 | 199 | 0.070 |
Why?
| | Pancreas | 2 | 2020 | 329 | 0.070 |
Why?
| | Quality of Life | 1 | 2019 | 2878 | 0.070 |
Why?
| | Models, Animal | 2 | 2019 | 384 | 0.070 |
Why?
| | Melanoma | 1 | 2013 | 757 | 0.060 |
Why?
| | Adolescent | 3 | 2021 | 21382 | 0.060 |
Why?
| | Risk Factors | 2 | 2019 | 10325 | 0.060 |
Why?
| | Patient Selection | 2 | 2019 | 690 | 0.050 |
Why?
| | Breast Neoplasms | 1 | 2015 | 2234 | 0.050 |
Why?
| | United States | 1 | 2020 | 14690 | 0.050 |
Why?
| | Biomarkers | 1 | 2014 | 4144 | 0.050 |
Why?
| | Catheters, Indwelling | 1 | 2023 | 91 | 0.050 |
Why?
| | Rats | 2 | 2020 | 5639 | 0.040 |
Why?
| | Immunity | 1 | 2021 | 143 | 0.040 |
Why?
| | Transplantation, Heterotopic | 1 | 2019 | 18 | 0.040 |
Why?
| | Rats, Inbred BN | 1 | 2019 | 58 | 0.040 |
Why?
| | Anastomosis, Surgical | 1 | 2020 | 152 | 0.040 |
Why?
| | Prosthesis Fitting | 1 | 2019 | 15 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2019 | 194 | 0.040 |
Why?
| | Bioprinting | 1 | 2019 | 29 | 0.040 |
Why?
| | Postoperative Period | 1 | 2019 | 342 | 0.040 |
Why?
| | Complement C4b | 1 | 2018 | 9 | 0.040 |
Why?
| | Myeloablative Agonists | 1 | 2018 | 22 | 0.040 |
Why?
| | Vidarabine | 1 | 2018 | 33 | 0.040 |
Why?
| | Abdominal Injuries | 1 | 2019 | 123 | 0.040 |
Why?
| | Printing, Three-Dimensional | 1 | 2019 | 94 | 0.040 |
Why?
| | Cryopreservation | 1 | 2019 | 98 | 0.040 |
Why?
| | Tissue Scaffolds | 1 | 2019 | 208 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2016 | 387 | 0.030 |
Why?
| | Autografts | 1 | 2015 | 44 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2019 | 752 | 0.030 |
Why?
| | Plasma | 1 | 2016 | 212 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1963 | 0.030 |
Why?
| | Hand-Assisted Laparoscopy | 1 | 2014 | 3 | 0.030 |
Why?
| | Liver Cirrhosis | 1 | 2016 | 316 | 0.030 |
Why?
| | Inguinal Canal | 1 | 2013 | 10 | 0.030 |
Why?
| | Neoadjuvant Therapy | 1 | 2016 | 403 | 0.030 |
Why?
| | Peptide Fragments | 1 | 2018 | 705 | 0.030 |
Why?
| | Cost Savings | 1 | 2014 | 84 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 2060 | 0.030 |
Why?
| | Mice | 2 | 2020 | 17757 | 0.020 |
Why?
| | Operating Rooms | 1 | 2014 | 123 | 0.020 |
Why?
| | Lymphatic Metastasis | 1 | 2013 | 351 | 0.020 |
Why?
| | Dogs | 1 | 2013 | 411 | 0.020 |
Why?
| | Decision Making | 1 | 2019 | 898 | 0.020 |
Why?
| | Registries | 1 | 2019 | 2015 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2014 | 587 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4013 | 0.020 |
Why?
| | Wound Healing | 1 | 2013 | 328 | 0.020 |
Why?
| | Survival Analysis | 1 | 2013 | 1321 | 0.020 |
Why?
| | Decision Support Techniques | 1 | 2014 | 418 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2020 | 5749 | 0.020 |
Why?
| | Age Factors | 1 | 2016 | 3284 | 0.020 |
Why?
| | Patient Readmission | 1 | 2014 | 694 | 0.020 |
Why?
| | Length of Stay | 1 | 2014 | 1205 | 0.020 |
Why?
| | Inflammation | 1 | 2019 | 2835 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 5742 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2013 | 3539 | 0.020 |
Why?
|
|
Etra's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|